Erste Asset Management Investment Blog

6 Ergebnisse zum Schlagwort “vaccine”

Artikel zu “vaccine”

COVID-19 Update: Moderna reports preliminary results from phase 3 vaccine trial
COVID-19 Update: Moderna reports preliminary results from phase 3 vaccine trial
(c) unsplash

COVID-19 Update: Moderna reports preliminary results from phase 3 vaccine trial

U.S. biotech company Moderna reported positive results from the first interim analysis of its Covid mRNA vaccine candidate. The IA found that of the 95 identified Covid cases in the study population 90 occurred in the placebo group, thus yielding a vaccine efficacy of 94,4%.

COVID-19 Update from the Investment Division: Russia to the Rescue?
COVID-19 Update from the Investment Division: Russia to the Rescue?
(c) unsplash

COVID-19 Update from the Investment Division: Russia to the Rescue?

Researchers from Moscow-based Gamaleya institute, an offshoot of the Russian Ministry of Health, published detailed phase 1/2 results of their COVID-19 vaccine in the Lancet. If true (remember that we are talking about Russia), these results imply that their vaccine is both effective and has a tolerable safety profile which would make it a strong contender in the international race to defeat COVID-19.

COVID19 Update: Sputnik V – the vaccine that came in from the cold
COVID19 Update: Sputnik V – the vaccine that came in from the cold
(c) unsplash

COVID19 Update: Sputnik V – the vaccine that came in from the cold

When Russian President Vladimir Putin celebrated his “Mission Accomplished” moment on August 11th with the announcement of Sputnik V, the world’s first SARS-CoV-2 vaccine, the global scientific community reacted with a mix of skepticism and condemnation. Is this warranted or a result of russophobia?